Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
N Engl J Med
.
2022 Jul 21;387(3):282.
doi: 10.1056/NEJMc2205922.
Authors
Walter R J Taylor
1
,
Julie Nguyen Pouplin
2
,
Andre Daher
3
Affiliations
1
Mahidol Oxford Tropical Medicine Clinical Research Unit, Bangkok, Thailand bob@tropmedres.ac.
2
Réseau Médicaments and Développement, Bordeaux, France.
3
Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
PMID:
35857668
DOI:
10.1056/NEJMc2205922
No abstract available
Publication types
Letter
Comment
MeSH terms
Antimalarials* / therapeutic use
Humans
Malaria, Vivax* / drug therapy
Malaria, Vivax* / prevention & control
Plasmodium vivax
Primaquine / therapeutic use
Recurrence
Substances
Antimalarials
Primaquine